MECHANISM OF ENHANCED TOXICITY OF 6-MERCAPTOPURINE WITH ENDOTOXIN

被引:5
作者
HIGUCHI, T [1 ]
NAKAMURA, T [1 ]
UCHINO, H [1 ]
机构
[1] KYOTO UNIV,FAC MED,DEPT INTERNAL MED,DIV 1,KYOTO 606,JAPAN
关键词
D O I
10.1016/0006-2952(78)90317-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The enhanced toxicity of 6-mercaptopurine with endotoxin has been confirmed with BALB/c male mice. Striking increases in thioinosinic acid were seen in mice pretreated with endotoxin before injection of 6-mercaptopurine, and were in agreement with the time course of the inhibiting effect of endotoxin on sleeping time. However, there were no significant differences in hypoxanthineguanine phosphoribosyltransferase between control mice and endotoxin-treated mice. Furthermore, there were significant increases in xanthine oxidase after treatment with endotoxin. It is clear that metabolism of 6-mercaptopurine might be modified by activity of the drug-metabolizing enzyme in mouse liver. Based on the effect of endoxotin on 6-mercaptopurine metabolism and the enzymes responsible for 6-mercaptopurine, it is suggested that death caused by 6-mercaptopurine-endotoxin combinations is due to an enhancement of the lethal effect of 6-mercaptopurine. Simultaneous administration of 6-mercaptopurine and endotoxin resulted in a parallel potentiation of either 6-mercaptopurine toxicity or endotoxin toxicity. This interaction was abolished in mice made resistant to the effects of endotoxin. Based on time of death, it is suggested that death caused by 6-mercaptopurineendotoxin combinations is due to an enhancement of the lethal effect of endotoxin. These results indicate that the underlying mechanism of the interaction may involve a dualistic enhancement of each agent. © 1978.
引用
收藏
页码:2507 / 2511
页数:5
相关论文
共 50 条
[31]   Comparative pharmacokinetics of oral 6-mercaptopurine and intravenous 6-mercaptopurine riboside in children [J].
Mawatari, H ;
Unei, K ;
Nishimura, S ;
Sakura, N ;
Ueda, K .
PEDIATRICS INTERNATIONAL, 2001, 43 (06) :673-677
[32]   Comparative structural and spectrum analyses of 6-mercaptopurine monohydrate and 6-mercaptopurine hydrochloride [J].
Perez-Ruiz, E ;
Delarbre, JL ;
Maury, L ;
Selkti, M ;
Tomas, A .
CANADIAN JOURNAL OF ANALYTICAL SCIENCES AND SPECTROSCOPY, 1998, 43 (03) :59-67
[33]   Adsorption of 6-mercaptopurine and 6-mercaptopurine riboside on silver colloid:: a pH dependent surface enhanced Raman spectroscopy and density functional theory study.: Part I.: 6-Mercaptopurine [J].
Szeghalmi, AV ;
Leopold, L ;
Pînzaru, S ;
Chis, V ;
Silaghi-Dumitrescu, I ;
Schmitt, M ;
Popp, J ;
Kiefer, W .
JOURNAL OF MOLECULAR STRUCTURE, 2005, 735 :103-113
[34]   ENHANCED BIOAVAILABILITY OF 6-MERCAPTOPURINE AFTER RECTAL ADMINISTRATION IN RATS [J].
KATO, Y ;
MATSUSHITA, T ;
YOKOYAMA, T ;
MOHRI, K .
PHARMACEUTICAL RESEARCH, 1992, 9 (05) :697-699
[35]   MECHANISM OF ACTION OF 6-MERCAPTOPURINE .2. BASIS FOR SPECIFICITY [J].
SALSER, JS ;
BALIS, ME .
CANCER RESEARCH, 1965, 25 (4P1) :544-&
[36]   MECHANISM OF INHIBITION OF ADENYLOSUCCINATE LYASE BY 6-MERCAPTOPURINE NUCLEOTIDE (THIOINOSINATE) [J].
BRIDGER, WA ;
COHEN, LH .
BIOCHIMICA ET BIOPHYSICA ACTA, 1963, 73 (03) :514-&
[37]   LEUKOPENIA INDUCTION CAPACITY AND TOXICITY OF 6-MERCAPTOPURINE PALLADIUM COMPLEX IN CHICK [J].
LEWIS, RW ;
MACK, RW .
FEDERATION PROCEEDINGS, 1968, 27 (02) :254-&
[38]   MECHANISM OF ACTION OF 6-MERCAPTOPURINE .I. BIOCHEMICAL EFFECTS [J].
SALSER, JS ;
BALIS, ME .
CANCER RESEARCH, 1965, 25 (4P1) :539-&
[39]   6-Mercaptopurine metabolism in Crohn's disease: Correlation with efficacy and toxicity [J].
Cuffari, C ;
Theoret, Y ;
Latour, S ;
Seidman, G .
GUT, 1996, 39 (03) :401-406
[40]   6-MERCAPTOPURINE ET THYROIDE [J].
CHEYMOL, J ;
LEVASSORT, C ;
DUREY, JM .
PRESSE MEDICALE, 1956, 64 (10) :217-217